The increase in the price target from $9.5 to $12 suggests that UBS sees potential for GCM Grosvenor's stock to appreciate, despite maintaining a Neutral rating. This could lead to a positive short-term impact on the stock price as investors may interpret the raised target as a sign of confidence in the company's future performance.